Literature DB >> 11802932

Candida dubliniensis candidaemia in an HIV-positive patient in Ireland.

Breida M Boyle1, D J Sullivan, C Forkin, F Mulcahy, C T Keane, D C Coleman.   

Abstract

Candida dubliniensis was first identified in Dublin in 1995 in oral isolates recovered from human immunodeficiency virus (HIV)-infected individuals. Although C. dubliniensis has been primarily recovered from the oral cavities of HIV-infected individuals, the number of reports describing its isolation from HIV-negative individuals, including cases of candidaemia, is growing. To date there has only been one report of C. dubliniensis candidaemia in an HIV-infected patient, in this case from the USA. In the present study, 2 Candida isolates recovered from blood samples were presumptively identified as C. dubliniensis on the basis of their dark green coloration on CHROMagar Candida medium and lack of growth at 45 degrees C. This identification was confirmed by carbohydrate assimilation profile analysis and by polymerase chain reaction (PCR) analysis with C. dubliniensis-specific PCR primers. Both isolates were susceptible to fluconazole. The isolates were found retrospectively to be from a single HIV-infected patient who was receiving broad-spectrum antibacterials at the time of isolation of C. dubliniensis from blood. This study represents the first documented case of C. dubliniensis bloodstream infection in Ireland and is only the second case of C. dubliniensis bloodstream infection identified in an HIV-infected individual anywhere in the world.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11802932     DOI: 10.1258/0956462021924497

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  5 in total

1.  Candida dubliniensis at a university hospital in Saudi Arabia.

Authors:  R Fotedar; S S A Al-Hedaithy
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

2.  Susceptibility of Candida dubliniensis to salivary histatin 3.

Authors:  Deirdre H Fitzgerald; David C Coleman; Brian C O'Connell
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

3.  The Candida dubliniensis CdCDR1 gene is not essential for fluconazole resistance.

Authors:  Gary Moran; Derek Sullivan; Joachim Morschhäuser; David Coleman
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

4.  Multilocus sequence typing reveals that the population structure of Candida dubliniensis is significantly less divergent than that of Candida albicans.

Authors:  Brenda A McManus; David C Coleman; Gary Moran; Emmanuelle Pinjon; Dorothée Diogo; Marie-Elisabeth Bougnoux; Silvia Borecká-Melkusova; Helena Bujdákova; Philip Murphy; Christophe d'Enfert; Derek J Sullivan
Journal:  J Clin Microbiol       Date:  2007-12-05       Impact factor: 5.948

5.  Candida dubliniensis: an appraisal of its clinical significance as a bloodstream pathogen.

Authors:  Ziauddin Khan; Suhail Ahmad; Leena Joseph; Rachel Chandy
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.